OraSure Technologies | OSUR - 销售和管理费用



金融业
股票价格
USD 3.72
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 274.5M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


销售和管理费用 更改 日
Agilent USD 475M 10M 2026-06
AngioDynamics USD 36.57M 3.79M 2025-09
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Bio Techne USD 67.42M 41.91M 2026-06
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 226.5M 12.4M 2026-09
Cerus USD 19.33M 1.55M 2024-12
Charles River Laboratories USD 140.59M 88.31M 2026-09
Danaher USD 2.16B 87M 2026-09
Dentsply International USD 364M 13M 2026-06
Dexcom USD 358.7M 9M 2026-06
Illumina USD 281M 8M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
IQVIA Holdings USD 569M 5M 2026-09
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Quidel USD 182.7M 7M 2026-09
Repligen USD 83.59M 6.97M 2026-09
Revvity USD 275.33M 3.25M 2026-09
STAAR Surgical USD 43.22M 1.92M 2026-09
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Trinity Biotech USD 4.71M 1.08M 2026-03
Waters USD 398M 7M 2026-09